13 Nov, EOD - Indian

Nifty Midcap 100 60692.05 (-0.35)

Nifty Next 50 69851.65 (0.06)

Nifty Pharma 22686.8 (0.41)

Nifty 50 25879.15 (0.01)

SENSEX 84478.67 (0.01)

Nifty IT 36679.45 (-0.48)

Nifty Smallcap 100 18183.65 (-0.37)

Nifty Bank 58381.95 (0.18)

13 Nov, EOD - Global

NIKKEI 225 51281.83 (0.43)

HANG SENG 27073.04 (0.56)

S&P 6875.5 (-0.18)


Corporate News

You are Here : Home > News > Corporate News >

(20 Sep 2025, 10:02)

Fischer Medical Ventures revises Final Dividend

Post Stock Split


Fischer Medical Ventures, post effectiveness of the Stock Split on 12th September 2025 from Rs.10 per share to Rs.1 per share, has revised the final dividend to Rs.0.005 per share of Rs.1 each. Earlier the board had declared a Dividend of Rs.0.05 per share of Rs.10 each.
More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +